معرفی
Anita Marton is a Researcher at the Department of Medicine, University of Fribourg, within the Faculty of Mathematics, Natural Sciences and Medicine. Her primary affiliation is the Department of Medicine, where she contributes to interdisciplinary medical research programs. She holds a position as Research Associate focusing on pharmacological mechanisms and inflammatory processes.
Her research interests center on poly(ADP-ribose) polymerase (PARP) inhibition, cardiovascular dysfunction, and inflammatory diseases. Key areas include developing novel therapeutic agents for age-related heart failure, sepsis, and diabetes-related vascular complications. She has explored adenosine derivatives, inosine, and other small molecules for their anti-inflammatory and cytoprotective effects.
Her work spans experimental models (murine, porcine, rat) investigating mechanisms of periodontitis, sepsis-induced organ damage, and endothelial dysfunction. She has also contributed to risk management methodologies in software development projects, demonstrating cross-disciplinary research capabilities.
Notable experimental approaches include evaluating PARP inhibitors in acute lung injury, studying flagellin's role in sepsis-related pulmonary inflammation, and analyzing cytokine modulation via adenosine receptors. Her preclinical studies bridge molecular mechanisms with translational medicine.
Marton's research emphasizes translational applications, with focus on drug candidates targeting inflammation and cellular necrosis. Her work has implications for critical care medicine, cardiology, and chronic disease management.
